Overview

A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Meda Pharmaceuticals
Treatments:
Carisoprodol